Doses of nicotine and lung carcinogens delivered to cigarette smokers

Journal of the National Cancer Institute

Volumn 92, Issue 2, 2000, Pages 106-111

  Djordjevic, Mirjana V ^a   Stellman, Steven D ^a   Zang, Edith ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; BENZO[A]PYRENE; CARBON MONOXIDE; NICOTINE; TAR;

ADULT; ARTICLE; CANCER RISK; CARCINOGENICITY; CIGARETTE SMOKING; HUMAN; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING CESSATION;

EID: 0034684985     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/92.2.106     Document Type: Article

References (48)

1. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 1999;91:675-90.
2. Doll R, Hill AB. Smoking and carcinoma of the lung. Preliminary report. Br Med J 1950;2:739-48.
3. Wynder EL, Graham EA. Tobacco smoking us a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proved cases. JAMA 1950;143:329-36.
4. International Agency for Research on Cancer (IARC). Tobacco smoking. Evaluation of the carcinogenic risk of chemicals to humans IARC Monogr 1986;38:1-421.
5. Wynder EL, Graham EA, Croninger AB. Experimental production of carcinoma with cigarette tar. Cancer Res 1953;13:855-64.
6. Wynder EL, Hoffmann D, editors. Tobacco and tobacco smoke: studies in experimental carcinogenesis. New York (NY): Academic Press; 1967. p. 1-730.
7. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997;50:307-64
8. Hoffmann D, Djordjevic MV, Brunnemann KD. Changes in cigarette design and composition over time and how they influence the yields of smoking constituents. National Institutes of Health/National Cancer Institute Smoking and Tobacco Control Monograph 1996;7:15-37.
9. Hoffmann D, Djordjevic MV, Hoffmann I. The changing cigarette. Prev Med 1997;26:427-34.
10. Jones EC, Norman AB. History of cigarette design. Rec Adv Tob Sei 1998;24:3-64.
11. Stellman SD, Muscat JE, Thompson S, Hoffmann D, Wynder EL. Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer 1997;80:382-8.
12. Stellman SD, Museal JE, Hoffmann D, Wynder EL. Impact of filter cigarette smoking on lung cancer histology. Prev Med 1997;26:451-6.
13. Thun MJ, Day-Lally CA, Calle EE, Flanders WD, Heath CW Jr. Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health 1995;85:1223-30.
14. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-203.
15. Russell MA. The case for medium-nicotine, low-tar, low-carbon monoxide cigarettes. Banbury Rep 1980;3:297-310.
16. Herning RI, Jones RT, Bachman J, Mines AH. Puff volume increases when low-nicotine cigarettes are smoked. Br Med J (Clin Res Ed) 1981;283: 187-9.
17. Kozlowski LT, Rickert WS, Pope MA, Robinson JC, Frecker RC. Estimating the yields to smokers of tar, nicotine, and carbon monoxide from the 'lowest yield' ventilated filter cigarettes. Br J Addict 1982;77:159-65.
18. Fagerstrom KO. Effects of a nicotine-enriched cigarette on nicotine titration, daily cigarette consumption, and levels of carbon monoxide, cotinine and nicotine. Psychopharmacology 1982;77:164-7.
19. Haley NJ, Sepkovic DW, Hoffmann D, Wynder EL. Cigarette smoking as a risk for cardiovascular disease. VI. Compensation with nicotine availability as a single variable. Clin Pharmacol Ther 1985;38:164-70.
20. Lubin JH, Blot WJ, Berrino F, Flamant R, Gillis CR, Kunze M, et al. Patterns of lung cancer risk according to type of cigarette smoked. Int J Cancer 1984;33:569-76.
21. Pillsbury HC, Bright CC, O'Connor KJ, Irish FW. Tar and nicotine in cigarette smoke. J Assoc Offic Anal Chem 1969;52:458-62.
22. U.S. Federal Trade Commission (FTC). Report of tar, nicotine, and carbon monoxide of the smoke of 1206 varieties of domestic cigarettes. Washington (DC): FTC; 1997.
23. Pfyl B. Zur Bestimmung des Nikotins II. Mitteilung. Z Lebensm Untersuch Forsch 1933;66:501-10.
24. Pyriki C. Verteilung von Nikotin im Rauch von Cigaretten. Chem Z 1934; 58:279-80.
25. Bradford JA, Harlan WR, Hanmer HR. Nature of cigarette smoke. Technic of experimental smoking. Ind Eng Chem 1936;28:836-9.
26. Djordjevic MV, Fan J, Ferguson S, Hoffmann D. Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes. Carcinogenesis 1995;16:2015-21.
27. Djordjevic MV, Hoffmann D, Hoffmann I. Nicotine regulates smoking pattern. Prev Med 1997;26:435-40.
28. Djordjevic MV. Hoffmann D, Thompson S, Stellman SD. Distribution of smoking parameters and self-administered doses of select smoke components among different population groups (abstract]. CORESTA Inform Bull (Paris) 1997;2:183.
29. Eberhardt HJ, Scherer G. Human smoking behavior in comparison with machine smoking methods: a summary of the five papers presented at the 1995 meeting of the CORESTA Smoke and Technology Groups in Vienna. Beitr Tabakforsch Intl 1995;16:131-40.
30. Robinson JH, Stiles MF, Davis RA, Guy TD, Morgan, W.T, Edwards DW, et al. Human smoking behavior measures on two new cigarettes that primarily heat tobacco. [Program and abstracts]. Richmond (VA): Philip Morris; 50th Tobacco Chemists' Research Conference [abstract 63]: 1996.
31. Federal Trade Commission. Cigarette testing. Request for public comment. Notice. Fed Reg III 1997;62:48,159.
32. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance questionnaire. Br J Addict 1991;86:1119-27.
33. Kozlowski LT, Pope MA, Lux JE. Prevalence of the misuse of ultra-low-tar cigarettes by blocking filter vents. Am J Publ Health 1988;78:694-5.
34. Puustinen P, Olkkonen H, Kolonen S, Tuomisto J. Microcomputer-aided measurement of puff parameters during smoking of low and medium-tar cigarettes. Scand J Clin Lab Invest 1987;47:655-60.
35. CORESTA Recommended Method No. 21. Atmosphere for conditioning and testing tobacco and tobacco products. CORESTA Inform Bull Special. Smoking Meth (Paris) 1991;3:123-5.
36. CORESTA Recommended Method No. 23. Determination of total and nicotine-free dry particulate matter using a routine analytical cigarette-smoking machine. Determination of total particulate matter and preparation for water and nicotine measurements. CORESTA Inform Bull Special. Smoking Meth (Paris) 1991;3:141-57.
37. CORESTA Recommended Method No. 8. Determination of water in the mainstream smoke of cigarettes by gas Chromatographic analysis. CORESTA Inform Bull Special. Smoking Meth (Paris) 1991;3:117-22.
38. CORESTA. Recommended Method 7. Determination of nicotine in the mainstream smoke of cigarettes by gas Chromatographic method. Bull Inform CORESTA Inform Bull Special. Smoking Meth (Paris) 1991;3: 112-5.
39. CORESTA Recommended Method No. 5. Determination of carbon monoxide in the mainstream smoke of cigarettes by non-dispersive infrared analysis. CORESTA Inform Bull (Paris) 1982;2:44-7.
40. Djordjevic MV, Brunnemann KD, Hoffmann D. Identification and analysis of a nicotine-derived N-nitrosamino acid and other nitrosamino acids in tobacco. Carcinogenesis 1989;10:1725-31.
41. Hoffmann D, Adams JD, Brunnemann KD, Hecht SS. Assessment of tobacco-specific N-nitrosamines in tobacco products. Cancer Res 1979;39: 2505-9.
42. Adams JD, Brunnemann KD, Hoffmann D. Chemical studies on tobacco smoke. LXXV. Rapid method for the analysis of tobacco-specific N-nitrosamines by gas-liquid chromatography with a thermal energy analyzer. J Chromatogr 1983;256:347-51.
43. Djordjevic MV, Sigountos CW, Hoffmann D, Brunnemann KD. Kagan MR, Bush LP, et al. Assessment of major carcinogens and alkaloids in the tobacco and mainstream smoke of USSR cigarettes. Int J Cancer 1991;47: 348-51.
44. Dumont J, Larocque-Lazure F, Iorio C. An alternative isolation procedure for the subsequent determination of benzo(a)pyrene in total particulate matter of cigarette smoke. J Chromatogr Sci 1993;31:371-4.
45. Risner CH. The determination of benzo(a)pyrene and benz(a)anthracene in mainstream and sidestream smoke of the Kentucky reference cigarette IR4F and a cigarette which heats but does not burn tobacco: a comparison. Beitr Tabakforsch 1991;15:11-8.
46. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J Toxicol Environ Health 1994;41:1-52.
47. Benowitz NL, Zevin S, Jacob P III. Source of variability of nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. Br J Clin Pharmacol 1997;43:259-67.
48. National Institutes of Health (NIH)/National Cancer Institute (NCI) Monograph No. 7. The FTC Cigarette Test Method for Determining Tar, Nicotine, and Carbon Monoxide Yields of U.S. Cigarettes. Report of the NCI Expert Committee. Bethesda (MD): NIH, NCI; 1996. (NIH Publ No. 96-4028).